| GC48338-500μg |
|
143452-11-3 |
|
0 |
— |
|
|
|
| GC48338-100μg |
|
143452-11-3 |
|
0 |
— |
|
|
|
| GC48337-500μg |
|
189759-03-3 |
|
0 |
— |
|
|
|
| GC48337-100μg |
|
189759-03-3 |
|
0 |
— |
|
|
|
| GC48336-25mg |
|
1234365-97-9 |
Tenapanor (hydrochloride)
|
0 |
— |
|
|
|
| GC48336-10mg |
|
1234365-97-9 |
Tenapanor (hydrochloride)
|
0 |
— |
|
|
|
| GC48336-5mg |
|
1234365-97-9 |
Tenapanor (hydrochloride)
|
0 |
— |
|
|
|
| GC48336-1mg |
|
1234365-97-9 |
Tenapanor (hydrochloride)
|
0 |
— |
|
|
|
| GC48335-500μg |
|
69345-49-9 |
N-glycolyl-Ganglioside GM3 Mixture (ammonium salt)
|
0 |
— |
|
|
|
| GC48334-500μg |
|
— |
Polymyxin B1 Isoleucine (sulfate)
|
0 |
— |
|
|
|
| GC48333-5mg |
|
69787-80-0 |
|
0 |
— |
|
|
|
| GC48333-1mg |
|
69787-80-0 |
|
0 |
— |
|
|
|
| GC48332-5mg |
|
— |
RR-Src (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48332-1mg |
|
— |
RR-Src (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48332-500μg |
|
— |
RR-Src (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48331-25mg |
|
— |
PLP (139-151) (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48331-10mg |
|
— |
PLP (139-151) (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48331-5mg |
|
— |
PLP (139-151) (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48331-1mg |
|
— |
PLP (139-151) (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48330-100μg |
|
— |
C3 BODIPY Ganglioside GM1 (d18:1/3:0) (ammonium salt)
|
0 |
— |
|
|
|
